Ethical considerations of COVID-19-related adjustments to clinical research.

Hsu, Nina S; Hendriks, Saskia; Ramos, Khara M; Grady, Christine

Hsu, Nina S; Hendriks, Saskia; Ramos, Khara M; Grady, Christine.

Hsu NS; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. nina.hsu@nih.gov.
Hendriks S; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Ramos KM; Department of Bioethics, NIH Clinical Center, Bethesda, MD, USA.
Grady C; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Nat Med ; 27(2): 191-193, 2021 02.

Article in English | MEDLINE | ID: covidwho-1047972

Subject(s)

Biomedical Research/ethics; COVID-19/epidemiology; SARS-CoV-2/physiology; COVID-19/virology; Humans; Pandemics; Risk Factors; Social Values

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biomedical Research / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-020-01216-2

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google